[184 Pages Report] The Mice Model Market size was estimated at USD 1.44 billion in 2023 and expected to reach USD 1.56 billion in 2024, at a CAGR 8.34% to reach USD 2.54 billion by 2030.
The use of mice models in life sciences research has become essential for learning a variety of human diseases as well as for creating and testing potential novel treatments. Various models are used; however, mice are particularly helpful as they share many human diseases and mammalian characteristics with humans. The rising cases of immune disease, cancer, and rare diseases have raised the need for adequate research activities, which has enhanced the usage of mouse models. However, the associated limitation and strict regulations and laws for animal models have restricted the use of mice models, which can hamper market development. Despite this, the increasing adoption of advanced technologies like AI and ML, coupled with the rising utilization of non-invasive assessment techniques on mice models, is anticipated to generate highly profitable opportunities for market expansion in the projected timeframe.
Regional Insights
The mice model market is significantly growing in the Americas due to continuous research activities by research organizations and pharmaceutical companies. Moreover, federal government support in terms of grants and investment for drug development and vaccine development has enhanced the scope of the mice model market. In addition, the rising genetic disease and neurological complications in European countries have increased the utilization of mouse models to understand age-related diseases. Moreover, emerging clinical research institutes and favorable government initiatives drive market development in the EMEA region. The rising need for personalized medications, surging geriatric disease, increasing cases of immune disease, and growing prevalence of infectious disease boost the adoption of mice models across the Americas and Europe regions. Furthermore, the presence of major players and ongoing developments of advanced technology in clinical trials is expected to create lucrative scope for the market. On the other hand, the Asia-Pacific region witnesses significant growth prospects of the mice models market in the forecast period due to growing research activities and government initiatives for clinical activities.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Mice Model Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Mice Model Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Mice Model Market, highlighting leading vendors and their innovative profiles. These include Applied StemCell, Inc., Aragen Life Sciences Ltd., Biocytogen Boston Corporation, Charles River Laboratories International, Inc., CompareNetworks, Inc., Creative Biolabs., Crown Bioscience by JSR Life Sciences, LLC, Cyagen US Inc. by PolyGene AG, Envigo by Inotiv, Inc., GenOway, Harbour BioMed, Horizon Discovery Ltd. by PerkinElmer, Inc., inGenious Targeting Laboratory, Inc., ITR Laboratories Canada, Janvier Labs, Marshall BioResources, MD Biosciences, Mirimus, Inc., Oncodesign, SA, Ozgene Pty Ltd., PhoenixBio Co., Ltd., Shanghai Model Organisms Center, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, TransCure bioServices, Translational Drug Development, LLC, Transnetyx, Inc., Urosphere SAS, Vivo Bio Tech Ltd., and XenOPAT SL by Bellvitge Biomedical Research Institute.
Market Segmentation & Coverage
This research report categorizes the Mice Model Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Service
- Breeding
- Cryopreservation
- Genetic Testing
- Model In-Licensing
- Quarantine
- Type
- Conditioned/Surgically Modified Mice
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Outbred Mice
- Technology
- CRISPER
- Embryonic Stem Cell Injection
- Genetically Modified Sperm-Mediated Gene Transfer
- Liposome-Mediated DNA & Electroporation of DNA
- Microinjection
- Nuclear Transfer
- TALENs & ZFNs
- Application
- Cardiovascular Studies
- Central Nervous System Studies
- Diabetes Studies
- Immunology & Inflammation Studies
- Oncology Studies
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Mice Model Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Mice Model Market?
- What are the technology trends and regulatory frameworks in the Mice Model Market?
- What is the market share of the leading vendors in the Mice Model Market?
- Which modes and strategic moves are suitable for entering the Mice Model Market?
US $
Euro €
GBP £
